CN111458321A - Diagnostic system based on lesion site fluorescence feedback - Google Patents

Diagnostic system based on lesion site fluorescence feedback Download PDF

Info

Publication number
CN111458321A
CN111458321A CN202010441713.7A CN202010441713A CN111458321A CN 111458321 A CN111458321 A CN 111458321A CN 202010441713 A CN202010441713 A CN 202010441713A CN 111458321 A CN111458321 A CN 111458321A
Authority
CN
China
Prior art keywords
sample
lesion site
diagnostic system
detection device
lesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010441713.7A
Other languages
Chinese (zh)
Other versions
CN111458321B (en
Inventor
蔡惠明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Nuoyuan Medical Devices Co Ltd
Original Assignee
Nanjing Nuoyuan Medical Devices Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Nuoyuan Medical Devices Co Ltd filed Critical Nanjing Nuoyuan Medical Devices Co Ltd
Priority to CN202010441713.7A priority Critical patent/CN111458321B/en
Publication of CN111458321A publication Critical patent/CN111458321A/en
Application granted granted Critical
Publication of CN111458321B publication Critical patent/CN111458321B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

The invention discloses a diagnostic system based on lesion site fluorescence feedback, which comprises a light source, a light filtering device, a sample accommodating device, a slide rail, an injection device, a first detection device, a second detection device and an information processing device, wherein the light filtering device is used for filtering light rays emitted from the light source; the light source, the filtering device, the sample accommodating device, the sliding rail, the injection device, the first detection device and the second detection device are in signal connection with the information processing device; the diagnosis system based on the lesion site fluorescence feedback occupies small space, is easy to operate, can find whether the tracer in a lesion site sample is sufficient or not and whether the illumination intensity is sufficient or not in time, and corrects the tracer to improve the detection efficiency.

Description

Diagnostic system based on lesion site fluorescence feedback
Technical Field
The invention relates to the field of medical treatment, in particular to a diagnosis system based on lesion site fluorescence feedback.
Background
Traditional tumor detection means, such as X-ray imaging, nuclear magnetic resonance imaging and the like, have a certain diagnosis rate, but instrument and equipment are heavy, the manufacturing cost is high, and the diagnosis cost is high, so that the methods are difficult to become effective means for tumor general investigation, and detection technologies such as B-ultrasonic and X-ray are more unknowable damages to human bodies and cannot be used as daily detection methods; therefore, a diagnosis system based on the fluorescence feedback of the lesion part, which occupies less space, has low cost and is convenient to operate, is needed.
Disclosure of Invention
The invention aims to provide a diagnostic system based on lesion site fluorescence feedback, and aims to solve the problems of large occupied space and difficulty in operation in the prior art.
In order to realize the purpose, the invention adopts the following technical scheme:
a diagnostic system based on lesion site fluorescence feedback comprises a light source, a light filtering device, a sample accommodating device, a sliding rail, an injection device, a first detection device, a second detection device and an information processing device, wherein the light filtering device is used for filtering light rays emitted from the light source, the sample accommodating device is used for accommodating a lesion site sample and is fixedly connected with the sliding rail, the injection device is used for accommodating a tracer and injecting the tracer into the lesion site sample, the first detection device is used for detecting the content of the tracer in the lesion site sample, and the second detection device is used for detecting the fluorescence intensity generated by the lesion site sample; the light source, the filter device, the sample containing device, the sliding rail, the injection device, the first detection device and the second detection device are in signal connection with the information processing device.
Preferably, the device further comprises a motor, and the motor is used for driving the sliding rail.
Preferably, the motor is in signal connection with the information processing device.
Preferably, the information processing apparatus is a microprocessor.
Preferably, the first detection device and the second detection device are both in signal connection with the information processing device through data lines.
Preferably, the first detection means comprises a probe for accessing the lesion sample.
Preferably, the second detection device is a photoelectric sensor.
Preferably, the light source is a laser with an adjustable incident angle.
Preferably, the wavelength of the laser is between 781-789 nm.
Preferably, the tracer is indocyanine green.
Compared with the prior art, the invention has the advantages that:
the diagnosis system based on the lesion site fluorescence feedback has the advantages of small occupied space and easy operation, can find whether the tracer in a lesion site sample is sufficient or not and whether the illumination intensity is sufficient or not in time, and corrects in time to improve the detection efficiency.
Drawings
FIG. 1 is a schematic diagram of a lesion site fluorescence feedback-based diagnostic system of the present invention.
The reference numbers in the figures illustrate:
1. a diagnostic system based on lesion site fluorescence feedback; 2. a light source; 3. a light filtering means; 4. a sample containment device; 5. a slide rail; 6. an injection device; 7. a first detection device; 8. a probe; 9. a second detection device; 10. a lesion site sample; 11. an information processing apparatus.
Detailed Description
The technical solution in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention; it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments, and all other embodiments obtained by those skilled in the art without any inventive work are within the scope of the present invention.
In the description of the present invention, it should be noted that the terms "upper", "lower", "inner", "outer", "top/bottom", and the like indicate orientations or positional relationships based on those shown in the drawings, and are only for convenience of description and simplification of description, but do not indicate or imply that the referred device or element must have a specific orientation, be constructed in a specific orientation, and be operated, and thus should not be construed as limiting the present invention. Furthermore, the terms "first" and "second" are used for descriptive purposes only and are not to be construed as indicating or implying relative importance.
In the description of the present invention, it should be noted that, unless otherwise specifically stated or limited, the terms "mounted," "disposed," "sleeved/connected," "connected," and the like are used in a broad sense, and for example, "connected" may be a fixed connection, a detachable connection, an integral connection, a mechanical connection, an electrical connection, a direct connection, an indirect connection through an intermediate medium, and a communication between two elements.
Referring to fig. 1, a diagnostic system 1 based on fluorescence feedback of a lesion site comprises a light source 2, a filter device 3, a sample container 4, a slide rail 5, an injection device 6, a first detection device 7, a second detection device 9 and an information processing device 11, wherein the filter device 3 is used for filtering light emitted from the light source 2, the sample container 4 is used for containing a lesion site sample 10, the sample container 4 is fixedly connected with the slide rail 5, the injection device 6 contains a tracer and is used for injecting the tracer into the lesion site sample 10, the first detection device 7 is used for detecting the content of the tracer in the lesion site sample 10, and the second detection device 9 is used for detecting the intensity of fluorescence generated by the lesion site sample 10; the light source 2, the filter device 3, the sample container 4, the slide rail 5, the injection device 6, the first detection device 7 and the second detection device 9 are all in signal connection with the information processing device 11.
The light source 2 is laser, the directivity of the laser is good, the divergence angle after emission is very small, the monochromaticity is good, the wavelength of the laser is between 781-789 nm, and the coherence is good; the laser can adjust the incident angle according to the requirement; the laser emitted from the light source 2 can be irradiated to the surface of the lesion part sample 10 after being filtered by the filter device 3; the sample containing device 4 is a tray, and the tray is fixedly connected with the slide rail 5, so that the position of the tray can be adjusted through the slide rail 5, or the incident angle of laser is adjusted, so that the incident light and the lesion part sample 10 are in the optimal position; after the sample 10 of the lesion part is irradiated by the laser, the fluorescence is generated due to the tracer, the fluorescence of the normal part is different from that of the product of the lesion part, and the condition of the lesion part can be judged by analyzing the fluorescence generated by the sample 10 of the lesion part.
In addition, after the first detection device 7 detects the content of the tracer in the lesion sample 10, the related information is sent to the information processing device 11, and after the information processing device 11 processes the related information, if the content of the tracer in the lesion sample 10 is found to be insufficient, a signal is sent to the injection device 6 to supplement and inject the tracer into the lesion sample 10; similarly, after the second detecting device 9 detects the fluorescence intensity of the surface of the lesion sample 10, it sends the relevant information to the information processing device 11, if the fluorescence intensity is found to be insufficient, it can send a signal to the light source 2 to increase the power of the laser, so that the fluorescence intensity of the lesion sample 10 can meet the requirement; if the tracer and the fluorescence intensity both meet the detection requirements, the lesion site sample 10 can be detected.
In order to improve the detection efficiency, the system is further provided with a motor which is in signal connection with the information processing device 11, the motor is used for driving the sliding rail 5, the information processing device 11 drives the sliding rail 5 through the motor so as to rapidly convey the tray to a specified position, and the sample 10 of the pathological change part is detected.
Preferably, the information processing device 11 is a microprocessor; meanwhile, in order to exchange information with the microprocessor stably and quickly, the first detection device 7 and the second detection device 9 are in signal connection with the microprocessor through data lines.
Preferably, the first detecting device 7 comprises a probe 8, and the probe 8 can enter the lesion sample 10 to detect the content of the tracer in the lesion sample 10, and send related data to the microprocessor, or receive signals sent by the microprocessor to detect the content of the tracer in different regions.
The second detecting device 9 is a photoelectric sensor, preferably a CCD, which is made of a semiconductor material with high light sensitivity, converts light into electric charges, converts the electric charges into digital signals through an analog-to-digital converter chip, and sends the digital signals to a microprocessor for processing, and receives instructions from the microprocessor to detect fluorescence; the tracer is indocyanine green, a common tracer.
By adopting the diagnostic system 1 based on the lesion part fluorescence feedback, the occupied space is small, the operation is easy, whether the tracer in the lesion part sample 10 is sufficient or not and whether the illumination intensity is sufficient or not can be found in time, and the microprocessor can correct the content and the illumination intensity of the tracer in time according to the detected data so as to improve the detection efficiency.
The foregoing is only a preferred embodiment of the present invention; the scope of the invention is not limited thereto. Any person skilled in the art should be able to cover the technical scope of the present invention by equivalent or modified solutions and modifications within the technical scope of the present invention.

Claims (10)

1. A diagnostic system based on lesion site fluorescence feedback, characterized by: the device comprises a light source, a light filtering device, a sample accommodating device, a slide rail, an injection device, a first detection device, a second detection device and an information processing device, wherein the light filtering device is used for filtering light rays emitted from the light source, the sample accommodating device is used for accommodating a sample of a lesion part, the sample accommodating device is fixedly connected with the slide rail, the injection device is accommodated with a tracer and is used for injecting the tracer into the sample of the lesion part, the first detection device is used for detecting the content of the tracer in the sample of the lesion part, and the second detection device is used for detecting the intensity of fluorescence generated by the sample of the lesion part; the light source, the filter device, the sample containing device, the sliding rail, the injection device, the first detection device and the second detection device are in signal connection with the information processing device.
2. The lesion site fluorescence feedback-based diagnostic system of claim 1, wherein: still include the motor, this motor is used for driving the slide rail.
3. The lesion site fluorescence feedback-based diagnostic system of claim 2, wherein: the motor is in signal connection with the information processing device.
4. The lesion site fluorescence feedback-based diagnostic system of claim 3, wherein: the information processing device is a microprocessor.
5. The lesion site fluorescence feedback-based diagnostic system of claim 1, wherein: and the first detection device and the second detection device are in signal connection with the information processing device through data lines.
6. The lesion site fluorescence feedback-based diagnostic system of claim 5, wherein: the first detection device includes a probe for accessing the lesion sample.
7. The lesion site fluorescence feedback-based diagnostic system of claim 6, wherein: the second detection device is a photoelectric sensor.
8. The lesion site fluorescence feedback-based diagnostic system of claim 1, wherein: the light source is laser with adjustable incident angle.
9. The lesion site fluorescence feedback-based diagnostic system of claim 8, wherein: the wavelength of the laser is between 781-789 nm.
10. The lesion site fluorescence feedback-based diagnostic system of claim 1, wherein: the tracer is indocyanine green.
CN202010441713.7A 2020-05-22 2020-05-22 Diagnostic system based on lesion site fluorescence feedback Active CN111458321B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010441713.7A CN111458321B (en) 2020-05-22 2020-05-22 Diagnostic system based on lesion site fluorescence feedback

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010441713.7A CN111458321B (en) 2020-05-22 2020-05-22 Diagnostic system based on lesion site fluorescence feedback

Publications (2)

Publication Number Publication Date
CN111458321A true CN111458321A (en) 2020-07-28
CN111458321B CN111458321B (en) 2021-11-23

Family

ID=71679612

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010441713.7A Active CN111458321B (en) 2020-05-22 2020-05-22 Diagnostic system based on lesion site fluorescence feedback

Country Status (1)

Country Link
CN (1) CN111458321B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112051250A (en) * 2020-09-09 2020-12-08 南京诺源医疗器械有限公司 Medical fluorescence imaging image light supplement adjusting system and adjusting method
CN112057046A (en) * 2020-09-10 2020-12-11 南京诺源医疗器械有限公司 Tumor fluorescence imaging spectrum diagnostic apparatus
CN116705215A (en) * 2023-08-04 2023-09-05 南京诺源医疗器械有限公司 Fluorescent marking system for detecting ventricle

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09308697A (en) * 1996-03-19 1997-12-02 Matsushita Electric Ind Co Ltd Method, system for fluorescent diagnosis and fluorescent diagnostic treatment system
JPH10309281A (en) * 1997-05-13 1998-11-24 Olympus Optical Co Ltd Fluorescent diagnostic device
CN101262817A (en) * 2005-09-13 2008-09-10 皇家飞利浦电子股份有限公司 Multiple contrast agent injection for imaging
CN101304684A (en) * 2005-11-10 2008-11-12 皇家飞利浦电子股份有限公司 Absorption and scattering map reconstruction for optical fluorescence tomography
CN101484067A (en) * 2006-07-07 2009-07-15 皇家飞利浦电子股份有限公司 Optical imaging system and method
CN101500486A (en) * 2005-08-16 2009-08-05 皮肤癌症扫描有限公司 Combined visual-optic and passive infra-red technologies and the corresponding system for detection and identification of skin cancer precursors, nevi and tumors for early diagnosis
CN101583304A (en) * 2007-01-18 2009-11-18 奥林巴斯株式会社 Fluorescence observing device and fluorescence observing method
CN107174215A (en) * 2017-06-28 2017-09-19 上海凯利泰医疗科技股份有限公司 A kind of spy fluorescence monitoring apparatus
CN207166606U (en) * 2017-07-11 2018-03-30 南京生命源医药实业有限公司 Medical imaging extraction element and system
CN108095687A (en) * 2012-05-18 2018-06-01 古斯塔夫·鲁西Igr研究所 Using red and remote red fluorescent dye biological tissue is characterized in cell grade
CN109171661A (en) * 2018-10-10 2019-01-11 南京诺源医疗器械有限公司 Fluoroscopic visualization checks system excitation light source
CN109222910A (en) * 2018-10-10 2019-01-18 南京诺源医疗器械有限公司 Fluorescence detection device
CN109363768A (en) * 2018-10-10 2019-02-22 南京诺源医疗器械有限公司 785nm wavelength light source near-infrared fluorescence imaging surgery guides system
CN109620163A (en) * 2019-01-18 2019-04-16 南京诺源医疗器械有限公司 A kind of tracer and tracing method

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09308697A (en) * 1996-03-19 1997-12-02 Matsushita Electric Ind Co Ltd Method, system for fluorescent diagnosis and fluorescent diagnostic treatment system
JPH10309281A (en) * 1997-05-13 1998-11-24 Olympus Optical Co Ltd Fluorescent diagnostic device
CN101500486A (en) * 2005-08-16 2009-08-05 皮肤癌症扫描有限公司 Combined visual-optic and passive infra-red technologies and the corresponding system for detection and identification of skin cancer precursors, nevi and tumors for early diagnosis
CN101262817A (en) * 2005-09-13 2008-09-10 皇家飞利浦电子股份有限公司 Multiple contrast agent injection for imaging
CN101304684A (en) * 2005-11-10 2008-11-12 皇家飞利浦电子股份有限公司 Absorption and scattering map reconstruction for optical fluorescence tomography
CN101484067A (en) * 2006-07-07 2009-07-15 皇家飞利浦电子股份有限公司 Optical imaging system and method
CN101583304A (en) * 2007-01-18 2009-11-18 奥林巴斯株式会社 Fluorescence observing device and fluorescence observing method
CN108095687A (en) * 2012-05-18 2018-06-01 古斯塔夫·鲁西Igr研究所 Using red and remote red fluorescent dye biological tissue is characterized in cell grade
CN107174215A (en) * 2017-06-28 2017-09-19 上海凯利泰医疗科技股份有限公司 A kind of spy fluorescence monitoring apparatus
CN207166606U (en) * 2017-07-11 2018-03-30 南京生命源医药实业有限公司 Medical imaging extraction element and system
CN109171661A (en) * 2018-10-10 2019-01-11 南京诺源医疗器械有限公司 Fluoroscopic visualization checks system excitation light source
CN109222910A (en) * 2018-10-10 2019-01-18 南京诺源医疗器械有限公司 Fluorescence detection device
CN109363768A (en) * 2018-10-10 2019-02-22 南京诺源医疗器械有限公司 785nm wavelength light source near-infrared fluorescence imaging surgery guides system
CN109620163A (en) * 2019-01-18 2019-04-16 南京诺源医疗器械有限公司 A kind of tracer and tracing method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王子阳: "近红外荧光导航肿瘤手术的最佳剂量和时间的研究", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112051250A (en) * 2020-09-09 2020-12-08 南京诺源医疗器械有限公司 Medical fluorescence imaging image light supplement adjusting system and adjusting method
CN112051250B (en) * 2020-09-09 2021-11-23 南京诺源医疗器械有限公司 Medical fluorescence imaging image light supplement adjusting system and adjusting method
CN112057046A (en) * 2020-09-10 2020-12-11 南京诺源医疗器械有限公司 Tumor fluorescence imaging spectrum diagnostic apparatus
CN116705215A (en) * 2023-08-04 2023-09-05 南京诺源医疗器械有限公司 Fluorescent marking system for detecting ventricle
CN116705215B (en) * 2023-08-04 2023-09-29 南京诺源医疗器械有限公司 Fluorescent marking system for detecting ventricle

Also Published As

Publication number Publication date
CN111458321B (en) 2021-11-23

Similar Documents

Publication Publication Date Title
CN111458321B (en) Diagnostic system based on lesion site fluorescence feedback
US8848872B2 (en) Digital radiography system
JP5623540B2 (en) Biological information acquisition and analysis device
CN106580264A (en) Terahertz wave attenuation total reflection imaging-based cerebral trauma tissue detection device
USRE41949E1 (en) System and method for tomographic imaging of dynamic properties of a scattering medium
US20140364743A1 (en) Near-infrared (nir) optical scanner
CN101410726A (en) Mammography system
CN103917859B (en) Biometric device, biometric method, program and recording medium
US20230280421A1 (en) Portable Handheld Magnetic Particle Imaging
CN103211620A (en) Breast carcinoma early-stage detecting instrument based on annular array opto-acoustic sensing technology
CN106618501B (en) Tumor imaging system based on near infrared spectrum blood oxygen concentration measurement and experimental detection method thereof
KR20110136710A (en) Table type digital x-ray detector, housing and x-ray photographing apparatus using the same
US20130109977A1 (en) Uv imaging for intraoperative tumor delineation
US20130096438A1 (en) Method and device for detecting tumorous tissue in the gastrointestinal tract with the aid of an endocapsule
US11931008B2 (en) Treatment support device and method of setting region of interest
CN103946689B (en) Biometric device and method
CN111012316B (en) Image reconstruction system of photoacoustic mammary gland
JP7144916B2 (en) Combined whole body PET and CT detector, and apparatus and method thereof
CN111458320A (en) Tracing system for tumor detection
CN101563026B (en) Imaging of a turbid medium
US6833915B2 (en) Optical diagnosis system for small animal imaging
KR100869782B1 (en) Bio-optical imaging system
CN111426671A (en) Imaging system based on fluorescence analysis
CN112345502A (en) Detector for eliminating fluorescence noise in fluorescence immunoassay analyzer
US20140288433A1 (en) Uv imaging for intraoperative tumor delineation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant